Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1976 Sep 1;144(3):754–767. doi: 10.1084/jem.144.3.754

Suppression of the antistreptolysin O response by cholesterol and by lipid extracts of rabbit skin

PMCID: PMC2190407  PMID: 182898

Abstract

Lipids extracted from rabbit skin block the hemolytic capacity of SO and also suppress the neutralizing antibody response to this streptococcal extracellular antigen in rabbith immunized intravenosly. The modification in antibody response is specific for SO; the antibody responses to streptococcal DNase B and to streptococcal NADase are not affected. Cholesterol, a lipid present in abundance in skin, has a similar specific effect on the antigenicity of SO and may be the component responsible for the demonstrated effects of these lipid extracts of skin. In vitro experiments indicate that lipid extracts of rabbit skin have a greater capacity to block the hemolytic capacity of SO than do lipid extracts of rabbit heart, kidney, lung, liver, or spleen. These data support the view that the feeble ASO response observed in patients with streptococcal pyoderma is a result of the abundance of a local lipid inhibitor, such as cholesterol, in the skin. They may also bear on the pathogenesis of rheumatic fever, a complication which apparently does not occur following group A streptococcal pyoderma. Two possible explanations for this remarkable epidemiologic observation, both related to the presence of a local inhibitor, are considered: (a) suppression of the ASO response, the magnitude of which has been correlated with the risk of developing rheumatic fever after streptococcal infection of the throat, and (b) inhibition of the toxicity of SO, which has been shown to have a direct toxic effect on the mammalian heart and on isolated beating myocytes.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson H. C., Kunkel H. G., McCarty M. QUANTITATIVE ANTISTREPTOKINASE STUDIES IN PATIENTS INFECTED WITH GROUP A HEMOLYTIC STREPTOCOCCI: A COMPARISON WITH SERUM ANTISTREPTOLYSIN AND GAMMA GLOBULIN LEVELS WITH SPECIAL REFERENCE TO THE OCCURRENCE OF RHEUMATIC FEVER. J Clin Invest. 1948 Jul;27(4):425–434. doi: 10.1172/JCI101986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anthony B. F., Kaplan E. L., Wannamaker L. W., Briese F. W., Chapman S. S. Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract. J Clin Invest. 1969 Sep;48(9):1697–1704. doi: 10.1172/JCI106135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anthony B. F., Perlman L. V., Wannamaker L. W. Skin infections and acute nephritis in American Indian children. Pediatrics. 1967 Feb;39(2):263–279. [PubMed] [Google Scholar]
  4. Ayoub E. M., Ferretti J. J. Use of bisulfite in the streptococcal anti-nicotinamide adenine dinucleotidase test. Appl Microbiol. 1966 May;14(3):391–393. doi: 10.1128/am.14.3.391-393.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BERNHEIMER A. W., CARLSON A. S., FREEMAN E. B., KELLNER A. Loss of myocardial contractility induced in isolated mammalian hearts by streptolysin O. J Exp Med. 1956 Sep 1;104(3):361–373. doi: 10.1084/jem.104.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bernheimer A. W., Cantoni G. L. THE CARDIOTOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : I. INCREASED SENSITIVITY OF THE ISOLATED FROG'S HEART TO REPEATED APPLICATION OF THE TOXIN. J Exp Med. 1945 Mar 1;81(3):295–306. doi: 10.1084/jem.81.3.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bisno A. L., Nelson K. E., Waytz P., Brunt J. Factors influencing serum antibody responses in streptococcal pyoderma. J Lab Clin Med. 1973 Mar;81(3):410–420. [PubMed] [Google Scholar]
  8. Dillon H. C., Jr Impetigo contagiosa: suppurative and non-suppurative complications. I. Clinical, bacteriologic, and epidemiologic characteristics of impetigo. Am J Dis Child. 1968 May;115(5):530–541. doi: 10.1001/archpedi.1968.02100010532002. [DOI] [PubMed] [Google Scholar]
  9. Dillon H. C., Jr, Reeves M. S. Streptococcal immune responses in nephritis after skin infections. Am J Med. 1974 Mar;56(3):333–346. doi: 10.1016/0002-9343(74)90615-9. [DOI] [PubMed] [Google Scholar]
  10. Edwards E. A. Protocol for micro antistreptolysin O determinations. J Bacteriol. 1964 May;87(5):1254–1255. doi: 10.1128/jb.87.5.1254-1255.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fehrenbach F. J. Identity of streptolysin-O and NAD-glycohydrolase (EC 3.2.2.5). Z Naturforsch B. 1971 Dec;26(12):1336–1338. doi: 10.1515/znb-1971-1224. [DOI] [PubMed] [Google Scholar]
  12. Ferrieri P., Dajani A. S., Wannamaker L. W., Chapman S. S. Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest. 1972 Nov;51(11):2851–2862. doi: 10.1172/JCI107108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ginsburg I. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. J Infect Dis. 1972 Sep;126(3):294–340. doi: 10.1093/infdis/126.3.294. [DOI] [PubMed] [Google Scholar]
  14. HALBERT S. P., BIRCHER R., DAHLE E. Studies on the mechanism of the lethal toxic action of streptolysin "O" and the protection by certain antiserotonin drugs. J Lab Clin Med. 1963 Mar;61:437–452. [PubMed] [Google Scholar]
  15. HALBERT S. P., BIRCHER R., DAHLE E. The analysis of streptococcal infections. V. Cardiotoxicity of streptolysin O for rabbits in vivo. J Exp Med. 1961 Apr 1;113:759–784. doi: 10.1084/jem.113.4.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HAM J. C. ACUTE INFECTIOUS OBSTRUCTING BRONCHIOLITIS: A POTENTIALLY FATAL DISEASE IN THE ADULT. Ann Intern Med. 1964 Jan;60:47–60. doi: 10.7326/0003-4819-60-1-47. [DOI] [PubMed] [Google Scholar]
  17. HARRIS S., HARRIS T. N. The measurement of neutralizing antibodies to streptococcal hyaluronidase by a turbidimetric method. J Immunol. 1949 Nov;63(3):233–247. [PubMed] [Google Scholar]
  18. KIRSCHNER L., HOWIE J. B. Rheumatio-like lesions in the heart of the rabbit experimentally induced by repeated inoculation with haemolytic streptococci. J Pathol Bacteriol. 1952 Apr;64(2):367–377. doi: 10.1002/path.1700640212. [DOI] [PubMed] [Google Scholar]
  19. Kaplan E. L., Anthony B. F., Chapman S. S., Ayoub E. M., Wannamaker L. W. The influence of the site of infection on the immune response to group A streptococci. J Clin Invest. 1970 Jul;49(7):1405–1414. doi: 10.1172/JCI106358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kaplan E. L., Wannamaker L. W. Dynamics of the immune response in rabbits immunized with spreptococcal extracellular antigens: comparison of the Streptozyme agglutination test with three specific neutralization tests. J Lab Clin Med. 1975 Jul;86(1):91–99. [PubMed] [Google Scholar]
  21. Kaplan E. L., Wannamaker L. W. Streptolysin O: suppression of its antigenicity by lipids extracted from skin. Proc Soc Exp Biol Med. 1974 May;146(1):205–208. doi: 10.3181/00379727-146-38070. [DOI] [PubMed] [Google Scholar]
  22. MARKOWITZ M., BRUTON H. D., KUTTNER A. G., CLUFF L. E. THE BACTERIOLOGIC FINDINGS, STREPTOCOCCAL IMMUNE RESPONSE, AND RENAL COMPLICATIONS IN CHILDREN AND IMPETIGO. Pediatrics. 1965 Mar;35:393–404. [PubMed] [Google Scholar]
  23. Maxted W. R., Fraser C. A., Parker M. T. Streptococcus pyogenes, type 49. A nephritogenic Streptococcus with a wide geographical distribution. Lancet. 1967 Mar 25;1(7491):641–644. doi: 10.1016/s0140-6736(67)92540-8. [DOI] [PubMed] [Google Scholar]
  24. NICOLAIDES N., ROTHMAN S. The site of sterol and squalene synthesis in the human skin. J Invest Dermatol. 1955 Feb;24(2):125–129. doi: 10.1038/jid.1955.20. [DOI] [PubMed] [Google Scholar]
  25. Nelson J., Ayoub E. M., Wannamaker L. W. Streptococcal anti-desoxyribonuclease B: microtechnique determination. J Lab Clin Med. 1968 May;71(5):867–873. [PubMed] [Google Scholar]
  26. PARKER M. T., TOMLINSON A. J., WILLIAMS R. E. Impetigo contagiosa; the association of certain types of Staphylococcus aureus and of Streptococcus pyogenes with superficial skin infections. J Hyg (Lond) 1955 Dec;53(4):458–473. doi: 10.1017/s0022172400000966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Potter E. V., Moran A. F., Poon-King T., Earle D. P. Characteristics of beta hemolytic streptococci associated with acute glomerulonephritis in Trinidad, West Indies. J Lab Clin Med. 1968 Jan;71(1):126–137. [PubMed] [Google Scholar]
  28. Prigent D., Alouf J. E., Raynaud M. Etude de la fixation de la streptolysine O radio-iodée sur les érythrocytes. C R Acad Sci Hebd Seances Acad Sci D. 1974 Jan 28;278(5):651–653. [PubMed] [Google Scholar]
  29. REINERTSON R. P., WHEATLEY V. R. Studies on the chemical composition of human epidermal lipids. J Invest Dermatol. 1959 Jan;32(1):49–59. [PubMed] [Google Scholar]
  30. Read S. E., Fischetti V. A., Utermohlen V., Falk R. E., Zabriskie J. B. Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest. 1974 Aug;54(2):439–450. doi: 10.1172/JCI107780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Shany S., Grushoff P. S., Bernheimer A. W. Physical separation of streptococcal nicotinamide adenine dinucleotide glycohydrolase from streptolysin O. Infect Immun. 1973 May;7(5):731–734. doi: 10.1128/iai.7.5.731-734.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Thompson A., Halbert S. P., Smith U. The toxicity of streptolysin O for beating mammalian heart cells in tissue culture. J Exp Med. 1970 Apr 1;131(4):745–763. doi: 10.1084/jem.131.4.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. WANNAMAKER L. W., AYOUB E. M. Antibody titers in acute rheumatic fever. Circulation. 1960 Apr;21:598–614. doi: 10.1161/01.cir.21.4.598. [DOI] [PubMed] [Google Scholar]
  34. WANNAMAKER L. W. Electrophoretic studies of the extracellular products of group A Streptococci. J Exp Med. 1958 Jun 1;107(6):783–795. doi: 10.1084/jem.107.6.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. WANNAMAKER L. W., PIERCE H. C. Family outbreak of acute nephritis associated with type 49 streptococcal infection. J Lancet. 1961 Dec;81:561–571. [PubMed] [Google Scholar]
  36. Wannamaker L. W. Differences between streptococcal infections of the throat and of the skin (second of two parts). N Engl J Med. 1970 Jan 8;282(2):78–85. doi: 10.1056/NEJM197001082820206. [DOI] [PubMed] [Google Scholar]
  37. Wannamaker L. W. The chain that links the heart to the throat. Circulation. 1973 Jul;48(1):9–18. doi: 10.1161/01.cir.48.1.9. [DOI] [PubMed] [Google Scholar]
  38. Watson K. C., Kerr E. J. Partial characterisation of an inhibitor of streptolysin O produced by bacterial growth in serum. J Med Microbiol. 1975 Nov;8(4):465–476. doi: 10.1099/00222615-8-4-465. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES